Clinical Trial Update: Proactive Protection With Azithromycin and hydroxyChloroquine in Hospitalized Patients With COVID-19 [Phase 2]

View source ↗

Summary

Phase 2 trial update on prophylactic use of azithromycin with hydroxychloroquine in hospitalized COVID-19 patients; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infection Viral
• Virus Diseases

Drugs mentioned

• Azithromycin (azithromycin)
• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: Chronic Obstructive Pulmonary Disease Trial Network, Denmark | Conditions: Virus Diseases, Infection Viral | Phase 2 | Status: TERMINATED | Results posted: 2021-06-28